1. Home
  2. FSEA vs SCLX Comparison

FSEA vs SCLX Comparison

Compare FSEA & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Seacoast Bancorp Inc.

FSEA

First Seacoast Bancorp Inc.

HOLD

Current Price

$16.69

Market Cap

52.7M

Sector

Finance

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$10.58

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSEA
SCLX
Founded
1890
2011
Country
United States
United States
Employees
N/A
30
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
52.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
FSEA
SCLX
Price
$16.69
$10.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.9K
66.6K
Earning Date
05-12-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.13
$3.95
52 Week High
$15.00
$34.27

Technical Indicators

Market Signals
Indicator
FSEA
SCLX
Relative Strength Index (RSI) 79.46 70.31
Support Level $11.10 $7.73
Resistance Level N/A $12.30
Average True Range (ATR) 0.36 1.10
MACD 0.37 0.52
Stochastic Oscillator 98.42 70.56

Price Performance

Historical Comparison
FSEA
SCLX

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is the savings and loan holding company. The banks business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one- to four-family residential real estate loans, commercial real estate and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. It operates in single segment of Banking Services.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: